Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases.

See DNDi‘s vision & mission and objectives.


DNDi is working on the following diseases:

Malaria Icon

Malaria
Portfolio handed over in 2015


GARDP IconIn 2016, in collaboration with the World Health Organization, DNDi launched the Global Antibiotic Research & Development Partnership (GARDP), a not-for-profit research and development organization to develop new antibiotic treatments addressing antimicrobial resistance and to promote their responsible use for optimal conservation, while ensuring equitable access for all.

 


20 entirely new chemical entities (NCEs) in the pipeline

210 staff
Half in endemic countries
Close to 1,000 people working on DNDi projects